Dr. Radcliffe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1305 York Ave
New York, NY 10021Phone+1 646-962-2020Fax+1 718-405-3808
Education & Training
- NYU Grossman School of MedicineResidency, Ophthalmology, 2004 - 2007
- University of HawaiiInternship, Transitional Year, 2003 - 2004
- Lewis Katz School of Medicine at Temple UniversityClass of 2003
Certifications & Licensure
- NY State Medical License 2004 - 2026
- HI State Medical License 2003 - 2004
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery Start of enrollment: 2020 Jan 13
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- New treatments for glaucoma.Anthony P Mai, Tanner J Ferguson, Nathan Radcliffe
Current Opinion in Ophthalmology. 2025-01-10 - Standalone Canaloplasty and Trabeculotomy Using the OMNI Surgical System in Eyes with Primary Open-Angle Glaucoma: A 36-Month Analysis from the American Academy of Oph...Nathan M Radcliffe, Jennifer Harris, Kristian Garcia, Erin Zwick, Robert T Chang
American Journal of Ophthalmology. 2024-12-24 - 1 citationsPreservatives and ocular surface disease: A review.Malik Y Kahook, Christopher J Rapuano, Elisabeth M Messmer, Nathan M Radcliffe, Anat Galor
The Ocular Surface. 2024-10-01
Press Mentions
- Sight Sciences Announces Real-World 36-Month Study Confirming Long-Term Effectiveness of Standalone OMNI Surgical System in Managing Primary Open-Angle GlaucomaJanuary 7th, 2025
- Ivantis Announces First Patient Enrolled in Pivotal Clinical Trial Evaluating the Hydrus Microstent in Standalone MIGS for Mild to Moderate GlaucomaDecember 15th, 2021
- CATS Tonometer LLC Receives FDA Clearance for Disposable Tonometer PrismJuly 13th, 2021
- Join now to see all
Professional Memberships
- Fellow
External Links
- Homepagehttp://www.drradcliffe.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: